Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2258]

ASCO 2023: Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumours

ASCO 2023: Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumours

HER3: Survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer

HER3: Survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer

What’s the relationship between cancer survivors’ tobacco use, symptom burden, and motivation to quit smoking?

What’s the relationship between cancer survivors’ tobacco use, symptom burden, and motivation to quit smoking?

Major study reveals how pancreatic cancer changes its ‘diet’ to survive

Major study reveals how pancreatic cancer changes its ‘diet’ to survive

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

NCCN global policy leader to co-chair GHC's non-communicable diseases roundtable

NCCN global policy leader to co-chair GHC's non-communicable diseases roundtable

Newly discovered RNA molecules hold promise for detecting and treating oesophageal cancer

Newly discovered RNA molecules hold promise for detecting and treating oesophageal cancer

Septic shock and metastases: finding the culprits

Septic shock and metastases: finding the culprits

Expansion of cell-to-cell communication drives the early development of pancreatic cancer, new research in mice finds

Expansion of cell-to-cell communication drives the early development of pancreatic cancer, new research in mice...

Research identifies biomarker that may predict treatment response to chemoimmunotherapy

Research identifies biomarker that may predict treatment response to chemoimmunotherapy

More from ecancer